Clinical Trials Browser

Phase 1 × Carcinoma, Hepatocellular × ascrinvacumab × Clear all

NCT01337050 2015-10-28

Asian Phase I Study Of PF-03446962

Phase 1 Completed

36 enrolled 24 charts

Gastrointestinal

Carcinoma, Hepatocellular, Neoplasms